Characterizing phospholamban to Sarco(endo)plasmic Reticulum Ca 2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking

Journal of Biological Chemistry

Volumn 287, Issue 10, 2012, Pages 7582-7593

  Akin, Brandy L ^a   Jones, Larry R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATP-ASE ACTIVITY; BINDING INTERACTION; CATALYTIC ACTIVATION; CHEMICAL CROSS-LINKING; CROSSLINKER; GLUTARATE; HUMAN HEART; INHIBITORY EFFECT; PHOSPHOLAMBAN; PHYSICAL INTERACTIONS; PROTEIN BINDING; SARCOPLASMIC RETICULUM; THAPSIGARGINS;

BINDING ENERGY; BIOCHEMISTRY; CROSSLINKING; PUMPS;

CALCIUM;

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; DISUCCINIMIDYL GLUTARATE; GLUTARIC ACID DERIVATIVE; LYSINE; PHOSPHOLAMBAN; PROTEIN 2D12; PROTEIN ANTIBODY; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; THAPSIGARGIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM TRANSPORT; CATALYSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CROSS LINKING; DOG; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SARCOPLASMIC RETICULUM;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CALCIUM; CALCIUM-BINDING PROTEINS; CELL LINE; CROSS-LINKING REAGENTS; HEART FAILURE; HUMANS; ION TRANSPORT; MICROSOMES; MUSCLE PROTEINS; MYOCARDIUM; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SPODOPTERA; THAPSIGARGIN;

EID: 84857711710     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.334987     Document Type: Article

References (39)

1. Simmerman, H. K., and Jones, L. R. (1998) Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78, 921-947 (Pubitemid 28491945)
2. Young, H. S., and Stokes, D. L. (2004) The mechanics of calcium transport. J. Membr. Biol. 198, 55-63 (Pubitemid 38581013)
3. Kimura, Y., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1997) Phospholamban inhibitory function is activated by depolymerization. J. Biol. Chem. 272, 15061-16064
4. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 272, 15872-15880
5. Cantilina, T., Sagara, Y., Inesi, G., and Jones, L. R. (1993) Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases: effect of a phospholamban antibody on enzyme activation by Ca2+. J. Biol. Chem. 268, 17018-17025 (Pubitemid 23236927)
6. Wegener, A. D., and Jones, L. R. (1984) Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels: evidence for a protein structure consisting of multiple identical phosphorylatable subunits. J. Biol. Chem. 259, 1834-1841 (Pubitemid 14146574)
7. Simmerman, H. K., Kobayashi, Y. M., Autry, J. M., and Jones, L. R. (1996) Aleucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J. Biol. Chem. 271, 5941-5946 (Pubitemid 26083936)
8. 2+)-ATPase: mechanism of regulation and site of monoclonal antibody interaction. J. Biol. Chem. 266, 11270-11275
9. 2+ uptake in mammalian ventricular myocytes. Am. J. Physiol. 261, H1344-1349
10. Vinge, L. E., Raake, P. W., and Koch, W. J. (2008) Gene therapy in heart failure. Circ. Res. 102, 1458-1470
11. 2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. J. Biol. Chem. 275, 15034-15038
12. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A. 100, 467-472
13. 2+ pump revealed by intermolecular thiol cross-linking. J. Biol. Chem. 277, 28319-28329
14. Bidwell, P., Blackwell, D. J., Hou, Z., Zima, A. V., and Robia, S. L. (2011) Phospholamban binds with differential affinity to calcium pump conformers. J. Biol. Chem. 286, 35044-35050
15. 2+ pump reveals stoichiometry and dynamic interactions between the two proteins. Biochem. J. 439, 313-319
16. Mueller, B., Karim, C. B., Negrashov, I. V., Kutchai, H., and Thomas, D. D. (2004) Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer. Biochemistry 43, 8754-8765 (Pubitemid 38880046)
17. 2+ pump of sarcoplasmic reticulum. Nature 342, 90-92
18. Li, J., Bigelow, D. J., and Squier, T. C. (2004) Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition. Biochemistry 43, 3870-3879 (Pubitemid 38437053)
19. Glaves, J. P., Trieber, C. A., Ceholski, D. K., Stokes, D. L., and Young, H. S. (2011) Phosphorylation and mutation of phospholamban alter physical interactions with the sarcoplasmic reticulum calcium pump. J. Mol. Biol. 405, 707-723
20. 2+ pump revealed with use of heterobifunctional cross-linking agents. J. Biol. Chem. 278, 48348-48356
21. 2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain. J. Biol. Chem. 281, 14163-14172
22. 2+pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 280, 10530-10539
23. 2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J. Biol. Chem. 282, 20968-20976
24. 2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state. J. Biol. Chem. 285, 28540-28552
25. Morita, T., Hussain, D., Asahi, M., Tsuda, T., Kurzydlowski, K., Toyoshima, C., and Maclennan, D. H. (2008) Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca2+-ATPase. Biochem. Biophys. Res. Commun. 369, 188-194 (Pubitemid 351381714)
26. Fujii, J., Zarain-Herzberg, A., Willard, H. F., Tada, M., and MacLennan, D. H. (1991) Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6. J. Biol. Chem. 266, 11669-11675 (Pubitemid 21907001)
27. Jones, L. R., and Cala, S. E. (1981) Biochemical evidence for functional heterogeneity of cardiac sarcoplasmic reticulum vesicles. J. Biol. Chem. 256, 11809-11818
28. 2+-ATPase. J. Biol. Chem. 270, 9390-9397
29. Gill, S. C., and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326 (Pubitemid 19277112)
30. Kho, C., Lee, A., Jeong, D., Oh, J. G., Chaanine, A. H., Kizana, E., Park, W. J., and Hajjar, R. J. (2011) SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601-605
31. 2+-ATPase. J. Biol. Chem. 283, 35703-35714
32. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J. Clin. Invest. 85, 1698-1702
33. 2+ transporting ATPase, phospholamban, and calsequestrin levels in non-failing and failing human myocardium. J. Clin. Invest. 90, 653-657
34. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc. Res. 31, 625-632
35. Hasenfuss, G. (1998) Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res. 37, 279-289
36. Ferrington, D. A., Yao, Q., Squier, T. C., and Bigelow, D. J. (2002) Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. Biochemistry 41, 13289 -13296
37. 2+-ATPase isoform of cardiac sarcoplasmic reticulum. J. Biol. Chem. 273, 14238-14241
38. 2+-ATPase superinhibition and cardiac remodeling. Circulation 113, 995-1004
39. Wang, H. S., Arvanitis, D. A., Dong, M., Niklewski, P. J., Zhao, W., Lam, C. K., Kranias, E. G., and Sanoudou, D. (2011) SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts. Physiol. Genomics 43, 357-364